ClinicalTrials.Veeva
Menu

Find clinical trials for Alzheimer's Disease in Kansas City, KS

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Alzheimer Disease
Dementia
Cognitive Dysfunction
Mental Disorders
Brain Diseases
Nervous System Diseases
Neurocognitive Disorders

Alzheimer's Disease trials near Kansas City, KS, USA:

A Study to Assess the Effects of ACI-24.060 in Alzheimer's Disease and in Down Syndrome (ABATE Study)

and pharmacodynamic effects of ACI-24.060 in subjects with prodromal Alzheimer's disease and in non-demented adults with Down syndr...

Enrolling
Prodromal Alzheimer's Disease
Alzheimer's Disease
Biological: Placebo
Biological: ACI-24.060 at Dose D

Phase 1, Phase 2

AC Immune

Fairway, Kansas, United States and 18 other locations

To investigate safety, tolerability, the effects on cognition and brain metabolism of pepinemab in early AD dementia (early AD) subjects.

Active, not recruiting
Alzheimer Disease
Drug: Placebo
Drug: Pepinemab

Phase 1, Phase 2

Vaccinex

Fairway, Kansas, United States and 13 other locations

is superior to placebo on change from baseline of the Preclinical Alzheimer Cognitive Composite 5 (PACC5) at 216 weeks of treatment (A45 Tri...

Enrolling
Preclinical Alzheimer's Disease
Early Preclinical Alzheimer's Disease
Drug: Lecanemab
Drug: Placebo

Phase 3

Eisai
Eisai

Fairway, Kansas, United States and 111 other locations

This study will be conducted to evaluate the efficacy of lecanemab in participants with early Alzheimer's disease (EAD) by determin...

Active, not recruiting
Early Alzheimer's Disease
Drug: Lecanemab
Drug: Placebo

Phase 3

Eisai
Eisai

Kansas City, Kansas, United States and 246 other locations

of emraclidine administered orally to healthy elderly participants in Part A (multiple ascending doses) and participants with dementia due to Alzheimer's...

Enrolling
Alzheimer's Disease Dementia
Healthy Participants
Drug: Emraclidine
Drug: Placebo

Phase 1

Cerevel Therapeutics
Cerevel Therapeutics

Overland Park, Kansas, United States and 3 other locations

The main purpose of this study is to evaluate the safety and efficacy of donanemab in participants with preclinical Alzheimer's Disease...

Enrolling
Alzheimer Disease
Drug: Donanemab
Drug: Placebo

Phase 3

Lilly
Lilly

Overland Park, Kansas, United States and 231 other locations

as measured by changes in the Clinical Dementia Rating Scale Sum of Boxes (CDR-SB) score as compared with placebo in participants with early Alzheimer's...

Active, not recruiting
Alzheimer's Disease
Drug: Aducanumab
Drug: Placebo

Phase 3

Biogen
Biogen

Fairway, Kansas, United States and 210 other locations

The reason for this study is to see how safe and effective the study drug donanemab is in participants with early Alzheimer's disease...

Active, not recruiting
Alzheimer Disease
Drug: Donanemab
Drug: Placebo

Phase 3

Lilly
Lilly

North Kansas City, Missouri, United States and 275 other locations

The primary objective is to evaluate the safety and tolerability of aducanumab over 100 weeks of treatment after a wash-out period imposed by discont...

Active, not recruiting
Alzheimer's Disease
Drug: Aducanumab

Phase 3

Biogen
Biogen

Fairway, Kansas, United States and 296 other locations

This is an extension study of the Phase 3 Studies 15-AVP-786-301, 15-AVP-786-302, and 17-AVP-786-305, which also allows participants from the Phase 2...

Enrolling
Agitation in Patients With Dementia of the Alzheimer's Type
Drug: AVP-786

Phase 3

Otsuka
Otsuka

Kansas City, Missouri, United States and 275 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems